SCHEMBL3544790

SCHEMBL3544790

CC/C=C/CCc1cc(C(=O)OC)cc(OC)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
KDM4E B2RXH2 3/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 3/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
TPMT P51580 1/20 0.39
SLC29A1 Q99808 1/20 0.39
EPHX2 P34913 1/20 0.38
CYP1A2 P05177 1/20 0.38
USP2 O75604 2/20 0.38
CYP2D6 P10635 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
POLB P06746 2/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3544793 1.00 TSHR (0.43) TSHRKDM4EKMT2AMEN1ALDH1A1
SCHEMBL3540602 0.88 TSHR (0.43) TSHRKDM4EKMT2AMEN1ALDH1A1
SCHEMBL3546331 0.88 TSHR (0.43) TSHRKDM4EKMT2AMEN1ALDH1A1
SCHEMBL3550555 0.85 TSHR (0.45) TSHRKDM4EKMT2AMEN1ALDH1A1
SCHEMBL3543246 0.84 TSHR (0.44) TSHRKDM4EKMT2AMEN1ALDH1A1
SCHEMBL3546673 0.83 PPARG (0.53) TSHRKDM4EKMT2AMEN1ALDH1A1
SCHEMBL3545411 0.81 ALOX5 (0.50) TSHRKDM4EKMT2AMEN1ALDH1A1
SCHEMBL3547886 0.80 ALOX5 (0.56) TSHRKDM4E
SCHEMBL3547720 0.78 ALOX5 (0.56) KMT2AMEN1
SCHEMBL3549887 0.78 CYP4A11 (0.49) TSHRKDM4EKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US disclosed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US disclosed
EP-1539744-A4 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARM INC (US) 2007-06-06 EP disclosed
EP-1539744-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2005-06-15 EP disclosed
WO-2004007444-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity AMDHD2, OGA, ENGASE TSHR 3540/4885KDM4E 2323/4885KMT2A 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.